1477P STK11 mutations predict poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status
| Autor: | De Giglio, A., de Biase, D., Di Federico, A., Maloberti, T., Casadio, C., Gruppioni, E., Altimari, A., Melotti, B., Sperandi, F., Gelsomino, F., Ardizzoni, A. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S836-S836 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|